REFERENCES
- Wilkie WL, Moore ES. Marketing's contributions to society. J Marketing. 1999; 63 (Special Issue):198–218.
- Hawkins DI, Best RJ, Coney KA. Consumer behavior: Implications for market-ing strategy. 6th ed. New York: Irwin; 1995.
- National Institute for Health Care Management and Research Foundation. Pre-scription drug expenditures in 2000: The upward trend continues. May 8, 2001.
- Lichtenberg, FR. The benefits and costs of newer drugs: evidence from the 1996 Medical Expenditure Panel Survey. National Bureau of Economic Research Working Paper No. W8147. March 2001.
- Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: Updating the cost-of-illness model. J Am Pharm Assoc. 2001; 41(2):192–9.
- PhRMA. Pharmaceutical companies target the diseases of aging with nearly 700 new medicines in development [resource on World Wide Web]. URL: http://www. phrma.org/publications/documents/factsheets//2000-08-01.179.phtml. Available from Internet. Accessed 2001 Mar 10.
- NIH research funding allocations correspond with some measures of disease bur-den, says New England Journal study [resource on World Wide Web]. URL: http://lrp. info.nih.gov/info/info 11 .htm. Available from Internet. Accessed 2001 Mar 10.
- Parsons T. The social system. Glencoe, IL: Free Press; 1951.